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creativecommons.org/licenses/by/4.0/).AIM: To evaluate a combined protocol for simultaneous cardiac MRI (CMR) and contrast-
enhanced (CE) whole-body MR angiography (WB-MRA) techniques within a single
examination.
MATERIALS AND METHODS: Asymptomatic volunteers (n ¼ 48) with low-moderate risk of
cardiovascular disease (CVD) were recruited. The protocol was divided into four sections: (1)
CMR of left ventricle (LV) structure and function; (2) CE-MRA of the head, neck, and thorax
followed by the distal lower limbs; (3) CMR LV “late gadolinium enhancement” assessment;
and (4) CE-MRA of the abdomen and pelvis followed by the proximal lower limbs. Multiple
observers undertook the image analysis.
RESULTS: For CMR, the mean ejection fraction (EF) was 67.3  4.8% and mean left ventricular
mass (LVM) was 100.3  22.8 g. The intra-observer repeatability for EF ranged from 2.1e4.7%
and from 9e12 g for LVM. Interobserver repeatability was 8.1% for EF and 19.1 g for LVM. No LV
delayed myocardial enhancement was observed. For WB-MRA, some degree of luminal nar-
rowing or stenosis was seen at 3.6% of the vessel segments (involving n ¼ 29 of 48 volunteers)
and interobserver radiological opinion was consistent in 96.7% of 1488 vessel segments
assessed.
CONCLUSION: Combined assessment of WB-MRA and CMR can be undertaken within a
single examination on a clinical MRI system. The associated analysis techniques are repeatable
and may be suitable for larger-scale cardiovascular MRI studies.
 2015 The Authors. Published by Elsevier Ltd on behalf of The Royal College of Radiologists.
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Cardiovascular disease (CVD) accounts for a signiﬁcant
burden of mortality and morbidity in developed societies.
Although the majority of CVD deaths are from coronary
heart disease (CHD) or stroke, the disease is often spread
across all vascular territories and may present elsewhere
ﬁrst, e.g., in the arteries of the legs. Disease in more than
one vascular bed (especially when involving the peripheral
arteries) is known to have a cumulative effect onworsening
prognosis, so early detection and stratiﬁcation of thewhole-
body burden of CVD (e.g., identifying those at highest risk of
sudden death through CHD or stroke) is desirable. Primary
prevention of CVD events is effective, but targeting suitable
treatment, such as protective drug therapy and/or proce-
dural interventions, to those most likely to beneﬁt remains
a challenge. Current decisions are based on estimated CVD
risk, but risk scores do not have good external validity, and a
signiﬁcant number of events occur in those deemed to be at
low or intermediate risk. Therefore, a method to screen for
“pre-clinical” cardiovascular disease may help to improve
how primary prevention is targeted.
Cardiac MRI (CMR) has developed into the imaging
standard for evaluating cardiac left ventricular (LV) struc-
ture and function.1,2 Numerous studies have deﬁned normal
ranges for LV parameters3,4 and these have been stratiﬁed
by demographics such as age,5 gender,6 and ethnicity.7
However, cardiac structure and function is only deemed to
represent part of the solution towards a more comprehen-
sive cardiovascular MRI assessment, where further desired
information would be provided by arterial luminal imaging
of the vascular tree.
Recent advances in MRI hardware such as radiofrequency
(RF) coil connectivity have resulted in the emergence of the
whole-bodyMRangiography (WB-MRA) technique,8,9which
can potentially add to a more comprehensive whole-body
cardiovascular assessment. The WB-MRA examination can
be performed using a “stepping table” approach10 or by the
use of continuously moving table methods.11 WB-MRA can
be performed on 1.512 or 3 T13 machines, but the use of a 3 T
MRI system is deemed to present an advantage14 by virtue of
the additional signal available that can be traded-off for
improved in-plane resolution or faster scan times. Reﬁne-
ment work to the WB-MRA technique at 3 T has previously
been reported and this has included the optimization of
single injection strategies,15 double injection strategies,16
and contrast medium dose optimization.17 The use of CMR
has also been validated at 3 T, where electrocardiogram
(ECG)-gated two-dimensional (2D) segmented cine steady-
state free precession (SSFP) techniques can be imple-
mented and compare favourablywithdata acquired at 1.5 T.18
For data analysis, quantitative methods for 3 T CMR are
widely described19,20 and LV segmentation can be per-
formed using a host of commercially available software
packages. However, WB-MRA is more suited to qualitative
approaches where scoring systems can report regional21 or
total22 indices of CVD, which can then be correlated with
symptoms in patients.23The present study was undertaken to incorporate CMR
and WB-MRA into a single 3 T “hybrid” clinical protocol
capable of acquiring images of the vascular tree together
with assessment of heart structure, function, and late gad-
olinium enhancement (LGE) within a single examination.
The protocol consists of four sections, each made up of se-
quences (that are all widely available on commercial MRI
systems) as follows: (1): CMR of LV structure and function;
(2) contrast-enhanced (CE)-MRA of the head/neck/thorax
and the distal lower limbs (contrast medium injection 1);
(3) CMR of LGE; and (4) CE-MRA of the abdomen/pelvis
(contrast medium injection 2).
To date, no work has been reported looking at the role of
this combined protocol in a low or intermediate risk cohort,
nor to assess the technical reproducibility of the study in
such a population. The primary objectives of the study were
therefore: (1) to implement this MRI protocol on a cohort of
asymptomatic volunteers with known risk of CVD but with
no previous clinical diagnosis; and (2) to evaluate data
analysis strategies for CMR and WB-MRA with input from
multiple observers in order to establish the intra- and
interobserver repeatability. WB-MRA combined with CMR
and LGE represents an attractive proposal for cardiovascular
work given its systemic assessment of the heart and
vascular tree. The WB-MRA technique on its own is known
to correlate better with future cardiovascular risk than
current scoring mechanisms in a high-risk population.12Materials and methods
Following local ethical committee approval, n ¼ 48 vol-
unteers (17 men, 31 women, mean age 54 years, range
41e71 years) were recruited after providing informed
consent. Inclusion criteria were as follows: (1) >40 years;
(2) free from CVD or other indication for statin therapy as
recommended by the Scottish Intercollegiate Guidelines
Network (SIGN) report 97 (www.sign.ac.uk) published in
February 2007, and (3) had a serum B-type natriuretic
peptide (BNP) level greater than their gender-speciﬁc me-
dian indicating non-speciﬁc stress on the cardiovascular
system. Exclusion criteria included: (1) pregnancy; (2)
known primary muscle disease; (3) known atherosclerotic
disease, including unstable angina, previous myocardial
infarction, peripheral arterial disease, amputation, revas-
cularization, hypertension, heart failure, or cerebrovascular
event; (4) known diabetes; (5) active liver disease; (6) other
known illness or contraindication to MRI; (7) participation
in a clinical trial; (8) inability to give informed consent; (9)
known alcohol abuse; and (10) blood pressure of greater
than 145/95 mmHg.
Imaging was performed (head-ﬁrst, supine orientation)
using a 3 T (102  32) Magnetom Trio Scanner (Siemens,
Erlangen, Germany) with a coil combination using head (12
elements), neck (four elements), body (two coils of six el-
ements each), spine (up to 24 elements), and peripheral
angiography (16 elements) RF coils. Preliminary three-plane
“localizer” images were acquired for WB-MRA via the use of
500 mm ﬁeld-of-view (FOV) gradient echo fast low-angle
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foot. Localizer images were positioned with an “overlap”
between each FOV of at least 75 mm but adjustable ac-
cording to patient height (Fig 1c). As part of the preparation
phase, localizer TurboFLASH images were also acquired of
the heart in the two-chamber (2ch), four-chamber (4ch)
and short axis (SA) orientations.
Protocol section 1: cine imaging and CMR of LV function
ECG-gated segmented breath-hold cine TrueFISP images
were acquired in the LV 4ch and 2ch orientations. Following
this, a stack of short axis images were acquired from the
atrio-ventricular ring to the LV apex using 2D ECG-gated
breath-hold segmented cine TrueFISP sequence with
retrospective gating (Table 1).
Protocol section 2: WB-MRA d stations 1 and 4
Unenhanced CE-MRA “mask” data were acquired for
each station using a 3D TurboFLASH sequence, and theFigure 1 Example CMR short axis data (a) at end-diastole, (b) at end-sys
year-old female patient with normal vascular segments. For WB-MRA, st
agent. Station 2 and 3 images are acquired after the second injection of con
must be taken with interpretation of vessels at the station boundaries, as
stenosis.scanner table was preset to move at a rate of 50 cm/s. A
10 ml “standard dose” of 0.05 mmol/ml gadoteric acid
(Dotarem, Guerbet, France) followed by 20 ml saline ﬂush
was delivered at the left or right antecubital fossa using a
Spectris Solaris power injector (MedRad, Pittsburgh, PA,
USA) at a rate of 1.5 ml/s. Timing was controlled by a coronal
2D Care Bolus acquisition (MR ﬂuoroscopy), and the
contrast-enhanced acquisition for station 1 commenced
when contrast agent arrival was noted at the top of the
aortic arch. Post-contrast data for station 4 were acquired
immediately after completion of station 1, and these were
acquired three times consecutively to account for variable
arterial transit times.
Protocol section 3: CMR of myocardial viability with
phase-sensitive inversion recovery (PSIR)
An ECG-gated segmented breath-hold 2D inversion-re-
covery prepared CINE TrueFISP “TI-Scout” sequence was
implemented (in a central short-axis position) 8e10 mintole, and (c) WB-MRA coronal plane MIP dataset acquired from a 50-
ation 1 and 4 images are acquired after the ﬁrst injection of contrast
trast agent. Overlap between stations is at least 75 mm; however, care
variable contrast medium in these areas has the potential to mimic a
Table 1
Imaging parameters for all sequences run within the combined cardiac MRI and whole-body MR angiography (WB-MRA) protocol.
Protocol section 1 1 2 2 3 3 4 4
Description CINE CINE WB-MRA WB-MRA TI scout PSIR WB-MRA WB-MRA
Location Heart Heart LV Station 1 Station 4 Heart LV Heart LV Station 2 Station 3
Sequence 2D TFi 2D TFi 3D TFl 3D TFl 2D TFi 2D PSIR 3D TFl 3D TFl
Cardiac phases 25 25 e e Variable e e e
ECG gating Retro Retro e e Pro Pro e e
Lines/segment 14 26 e e 9 25 e e
Orientation 4ch & 2ch SA Coronal Coronal SA SA Coronal Coronal
TR/TE (ms) 3.37/1.48 3.37/1.48 2.68/1 2.61/0.96 3.11/1.39 5.21/1.99 2.6/0.96 3.47/1.21
FA () >50 >50 19 22 35 20 16 37
FOV (mm) >360 >360 360  500 360  500 >360 >360 344  500 344  500
Phase FOV (%) 84.4 84.4 71.9 68.8 81.3 75 68.8 71.9
Section thickness (mm) 6 6 1.1 1 8 6 1.3 1.4
Sections (n) 1 2 96 80 1 2 96 96
Matrix (pixels) 216  256 173  256 313  512 277  448 78  192 144  256 264  512 242  448
Voxel size (mm) Variable Variable 1.1  1.0  1.1 1.2  1.1  1.0 Variable Variable 1.3  1.0  1.3 1.5  1.1  1.4
Parallel imaging 2 2 3 3 e 2 3 3
K-space Linear Linear Linear 3D centric Centric Linear 3D centric 3D centric
BW (Hz/pix) 930 930 700 700 965 287 700 740
Scan time (s) <20 <20 18 14 <20 <20 14 16
LV, left ventricle; TFi, TrueFISP; TFL, TurboFLASH; PSIR, phase sensitive inversion recovery; Retro, retrospective; Pro, prospective; 4ch, four chamber; 2ch, two
chamber; SA, short axis; TR, repetition time; TE, echo time; TI, inversion time; FA, ﬂip angle; FOV, ﬁeld of view; i-PAT, integrated parallel acquisition technique;
BW, bandwidth.
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the null point inversion time (TI) for the myocardium.
Subsequently, at a mean of 11 min post-contrast medium
administration (range 9e16 minutes) a short-axis stack of
ECG-gated segmented 2D PSIR images were acquired in
order to highlight any LGE within the myocardium. The
mean TI used was 376 ms (range 300e450 ms).
Protocol section 4: WB-MRA d stations 2 and 3
Unenhanced 3D Turbo-FLASH “mask” data were acquired
for each station (Table 1). The second contrast agent dosewas
delivered the sameasbeforebut this time the “standarddose”
was 15ml, infused at 1.5ml/s followedbya 20ml salineﬂush.
Timing was again controlled by 2D Care Bolus (coronal plane
abdominal aorta), and post-contrast scans for station 2 were
triggered when the bolus could be seen arriving in the
abdominal aorta. Post-contrast data for station 3 were ac-
quired immediately after completion of the station 2
sequence.Theaverage timebetweenﬁrst andsecondcontrast
agent injections was 19 min (range 15e34 min).
Finally, the pre- and post-contrast WB-MRA data were
subtracted and the resulting images were stitched using a
multi-modality work platform (MMWP; Composing,
Siemens, Erlangen, Germany). Multiplanar reconstructions
(MPR) and maximum intensity projections (MIP) were also
generated for further radiological interpretation.
Image analysis
For CMR, all datasets (n ¼ 48) were analysed once by
each of a team of four experienced medical physics ob-
servers in order to assess interobserver variation. Addi-
tionally the datasets were divided into four groups of
n¼ 12, and one group was assigned to each medical physics
observer for further segmentation, resulting in fourindependent assessments of intra-observer variation. For
WB-MRA, all datasets were analysed once by each of a team
of four radiologist observers in order to derive interobserver
variation. Again the datasets were divided into four groups
of n ¼ 12, and one group was assigned to each radiologist
observer for further segmentation, resulting in four inde-
pendent assessments of intra-observer variation. Dataset
randomization was performed by an independent support
statistician (P.R.). Repeat analysis was separated by at least 1
month in order to eliminate “learning effects” by observers.
CMR images were analysed using commercial software
(Argus, Siemens Multi-modality Work Platform, version VB
15). Region of interest (ROI) contours were placed around
endocardial and epicardial LV borders on all CMR image
sections at end-diastole and end-systole that contained 50%
or more full-thickness myocardium. Quantitative mea-
surements of EF and LVM (at end-diastole) were derived.
Papillary muscles were included in the LVM if indistin-
guishable from the myocardial wall, but otherwise assigned
to the left ventricular blood pool.
WB-MRA analysis was performed using a diagnostic
PACS radiological workstation (Carestream PACS Client
Suite Version 10.1 sp1, Rochester, NY, USA) on the post-
contrast TurboFLASH source images, with MIP and MPR
images for further interpretation. Analysis was performed
on 31 arterial segments per dataset (Table 2). Radiological
stenosis grading was performed by a visual examination of
each vessel segment, and stenoses (if present) were recor-
ded as a percentage of luminal diameter loss relative to a
distal healthy segment. If more than one stenosis was pre-
sent the most severe was assessed. The subdivision of
longer arteries into smaller segments was performed to
ensure that the presence of multiple pathologies affecting
any particular arterial segment could be captured. A grading
scale of 0e4 was applied to each arterial segment as fol-
lows: grade 0 ¼ healthy segment, grade 1 ¼1e50% stenosis,
Table 2
Number of abnormal arterial assessments within the cohort (from a possible
n ¼ 48 for each location) identiﬁed by a consensus of four radiologist ob-
servers with cardiovascular MRI experience.
Arterial
segment
Grade 1 Grade 2 Grade 3 Grade 4 Total (%) Fleiss’
kappa
R int. carotid 0 0 0 0 0 (0%) 0.89
L int. carotid 2 0 0 0 2 (4.2%) 0.90
R vertebral 0 0 0 0 0 (0%) 0.97
L vertebral 0 0 0 0 0 (0%) 0.94
Aortic arch 0 0 0 0 0 (0%) 0.99
Innominate 0 0 0 0 0 (0%) 1
R com. carotid 0 0 0 0 0 (0%) 0.99
L com. carotid 1 0 0 0 1 (2.1%) 0.93
R subclavian 2 0 0 0 2 (4.2%) 0.88
L subclavian 0 0 0 0 0 (0%) 0.90
Thoracic aorta 1 0 0 0 1 (2.1%) 0.86
Abdominal aorta 10 0 0 0 10 (21%) 0.81
Coeliac trunk 6 5 6 1 18 (37.5%) 0.66
Sup. mesenteric 1 0 0 0 1 (2.1%) 0.88
Inf. mesenteric 0 0 1 0 1 (2.1%) 0.91
R renal 1 0 0 0 1 (2.1%) 0.93
L renal 0 0 0 0 0 (0%) 0.94
R iliac 4 0 0 0 4 (8.4%) 0.90
L iliac 3 0 1 0 4 (8.4%) 0.87
R femoral 1 0 0 0 1 (2.1%) 0.91
L femoral 2 0 0 0 2 (4.2%) 0.91
R profunda 0 0 0 0 0 (0%) 0.96
L profunda 0 0 0 0 0 (0%) 0.99
R popliteal 0 0 0 0 0 (0%) 0.97
L popliteal 0 0 0 0 0 (0%) 1
R ant. tibial 0 0 0 0 0 (0%) 0.93
L ant. tibial 0 0 0 0 0 (0%) 0.97
R peroneal 0 0 1 0 1 (2.1%) 0.96
L peroneal 0 0 2 0 2 (4.2%) 0.95
R post. tibial 0 0 0 1 1 (2.1%) 0.96
L post. tibial 0 0 0 1 1 (2.1%) 0.93
The frequency of disease was highest at the coeliac axis.
Interobserver agreement for each site is described by Fleiss’ kappa statistic.
R, right; L, left; Int, internal; Com, common; Sup, superior; Inf, inferior; Ant,
anterior; Post, posterior.
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grade 4 ¼ occlusion. Non-diagnostic segments were recor-
ded as “non-interpretable”. Finally, the vessel scores were
summated on a per-volunteer basis to form a total atheroma
burden score for each volunteer, and from this a standard-
ized atheroma score (SAS) was derived using equation (1),
which expresses a generalized atheroma burden severity











For the CMR LV function data, intra- and interobserver
coefﬁcients of repeatability (CoR) for EF and LVM were
calculated as 2.77(Sw)0.5, where Sw is the within-subject
standard deviation. One-way analysis of variance (ANOVA)
was implemented (with 95% conﬁdence limits) in order to
highlight any signiﬁcant differences between the means of
the EF and LVM parameters both within and between ob-
servers. A minor variation to the standard BlandeAltmanplot was used to illustrate interobserver variation for EF and
LVM.24 For the WB-MRA data, agreement in stenosis
grading was calculated using Fleiss’ kappa statistic (k) for
interobserver measures. Variability in whole-body
atheroma scoring was assessed using the KruskaleWallis
test for multiple observations and theWilcoxon signed rank
test was used to test for observational pairs of data. Statis-
tical analysis was performed using IBM SPSS, version 21
(Chicago, IL, USA).Results
The CMR and WB-MRA datasets were acquired success-
fully and provided analysable data for all sequences and
arterial segments, although one WB-MRA arterial segment
(out of 1488) was deemed non-interpretable and excluded
from further analysis. An example image dataset high-
lighting CMR (LV short axis) and the corresponding WB-
MRA is illustrated in Fig 1, and examples of WB-MRA
highlighting vascular disease are illustrated in Fig 2. The
mean examination time was 51 min, although this was
variable (standard deviation  10 min) and depended upon
the patient size and the need for extra shimming steps in
some cases.
For CMR, mean values (derived by n ¼ 4 medical physics
observers) for EF ranged from 65.3  5.1% to 71.1  4.7%,
with a consensus mean of 67.3  4.8% (for n ¼ 48 patients).
For LVM, mean values ranged from 92.8  22.1 g to
105.3  22 g, with a consensus mean of 100.3  22.8 g
(when normalized to body surface area,25 the mean LVM
index values ranged from 49.4 9.3 g/m2 to 56.18.7 g/m2
with a consensus mean of 53.3  9.1 g/m2). There were no
cases of myocardial LGE identiﬁed by the radiologist
observers.
Data plots for multiple observers are presented in Fig 3,
highlighting the variation in interobserver repeatability for
EF and LVM. For EF, observer 3 tended to generate values
that were larger than those from the other observers
(p< 0.05). However, when EF data derived by the remaining
observers were evaluated, there was no statistical differ-
ence detected between their means. The single-measure
interobserver CoR for EF was 8.1%, and for each individual
observer the test-retest intra-observer CoR for EF was 4.7%
(observer 1), 2.1% (observer 2), 2.7% (observer 3) and 3%
(observer 4). For LVM, observer 1 tended to generate values
that were smaller than those from the other observers
(p < 0.05). Again, when LVM data derived by the remaining
observers were considered there was no statistical signiﬁ-
cance detected between their means. The single-measure
interobserver CoR for LVM was 19.1 g, and for each indi-
vidual observer the test-retest intra-observer CoR for LVM
was 9 g (observer 1), 10.2 g (observer 2), 10.1 g (observer 3)
and 12 g (observer 4).
For WB-MRA, of the 1488 arterial segments evaluated
(31 anatomical locations for 48 volunteers) there was evi-
dence of vessel luminal narrowing or stenosis in 53 (3.6%)
segments, involving n ¼ 29 volunteers. Details of the arte-
rial segments where disease was noted by consensus are
Figure 2 Example images highlighting stenoses (arrowed) in common iliac arteries on (left) a source image, and (right) a MIP image of the
abdominal station of a 60-year-old woman. Of particular interest is the fact that the source images have been useful on this occasion for
identifying pathology in the right iliac artery, which is not noted on the MIP reconstruction.
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was detected, 34 cases were scored as grade 1 (minor ste-
nosis 1e50%), ﬁve cases were scored as grade 2 (moderate
stenosis 51e70%), 11 cases were scored as grade 3 (severe
stenosis 70e99%), and three cases were scored as grade 4
(vessel occlusion). However, the vast majority of segments
were considered radiologically normal.
The greatest frequency of luminal narrowing was noted
at the coeliac axis, where a stenosis score of grade 1 or more
was noted in 18 of the volunteers. This was followed by the
abdominal aorta (10 cases), and the right and left iliac ar-
teries (four cases each). At all other segments, luminal
narrowing was only ever noted in two (or less) of the 48
volunteers.
Independent single assessments of all datasets by each
radiologist observer resulted in identical scoring between
all four radiologist observers in 1277 (85.8%) of the 1488
arterial segments evaluated. Of those not scored identically,
clear consensus agreement between three out of four
radiologist observers was recorded for 162 (10.9%) of the
segments. Radiological opinion was divided at the remain-
ing 49 segments, i.e., 3.3% of the total reviewed. Fleiss’
kappa values are listed for each of the arterial segments
under investigation as a measure of interobserver agree-
ment (Table 2). Worst case agreement was found at the
coeliac axis (k¼ 0.66) and best case agreement was found at
the innominate and left popliteal arteries (k ¼ 1.00).
Intra-observer repeatability (derived from four equal
subsets of n ¼ 12 volunteers) resulted in radiologist ob-
servers 1 and 2 achieving consistent scoring in 356 (95.7%)
of 372 arterial segments. For radiologist observers 3 and 4,
consistent scoring was achieved in 346 (93%) and 350
(94.1%) of the segments respectively.The median SAS score (equation 1) by consensus was
0.8%, and ranged from 0% to 5.6%. When the scores were
evaluated between observers (using the KruskaleWallis
test), there was no signiﬁcant difference detected between
the means of those provided by each radiologist observer
(p ¼ 0.14). Further, a subset of n ¼ 12 volunteers were
evaluated by each radiologist observer for a second time
and when the SAS scores were compared on a per-
radiologist basis (using the Wilcoxon signed rank test),
there was no signiﬁcant difference between the means of
the ﬁrst and second assessments (p ¼ 0.74, p ¼ 0.64,
p ¼ 0.71, and p ¼ 0.71 for radiologist observers 1e4,
respectively).
Discussion
In the present study, a hybrid cardiovascular clinical MRI
protocol was implemented from existing clinical sequences
in order to acquire CE-MRA images of the human vascular
tree together with assessment of heart structure, function,
and LGE within a single examination. The data analysis
methods are repeatable and all techniques are available on
commercial systems, which allows for use at other centres.
The CMR arm of the protocol was implemented using
recent recommendations.1,26 Mean values for EF and LVM
achieved overlap with published normal ranges,3,27
although the mean value for LVM reported here is at the
lower end. This is likely to be due to the segmentation
approach, where contentious areas at the basal end of the
LV were omitted if the section contained <50% full-
thickness myocardium. This approach is particularly
important for studies where MRI is used to detect small
changes in LVM over time or in response to intervention.28
Figure 3 Interobserver data for EF (%) and LVM (g). Circles, observer 1; squares, observer 2; triangles, observer 3; and crosses, observer 4. The
hashed lines represent two standard deviations from the mean difference between observers.
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acquisition and analysis between observers, and not the
reporting of the LVM index (relative to body surface area), as
the objective was more to identify a robust and repeatable
protocol.
There are certain limitations associated with the CMR
work reported here. The segmentation repeatability was
optimized by consensus choice of basal section inclusion
between observers. This approach was taken since any
study involving the assessment of LVM using CMR (e.g., a
longitudinal investigation) would normally account for
consistency within the section ranges included. Therefore,
the consensus choice resulted in a CoR that was represen-
tative of boundary contour placements. Even with this
additional step included, the interobserver repeatability of19.1 g was still quite variable but this is very much consis-
tent with ﬁndings described in detail elsewhere where “real
world” LVM inconsistencies of typically 28% may be ex-
pected for a large cohort.29 It is an inescapable fact that
variability between experienced observers does still arise,
even with the use of careful rules for how to deal with
papillary muscles and trabeculae. This is further borne out
from our work where far better repeatability was estab-
lished for intra-observer data (CoR range 9e12 g for LVM).
For WB-MRA, the two-injection “standard dose”
approach was chosen for three reasons. Firstly, the use of
two stations per injection allowed for more sensitive con-
trol of bolus timing, and therefore, reliable arterial phase
images. A single-injection approach was considered, but it
was felt that this would require the use of less widely
S.J. Gandy et al. / Clinical Radiology 70 (2015) 595e603602available time-resolved MRA techniques in order to ensure
arterial phase data across the entire arterial tree. Secondly,
the use of a contrast agent “standard dose” approach has
been previously described on a similar cohort,17 where a
dose reduction strategy (10 ml for injection 1 followed by
15ml for injection 2) was recommended based on improved
SNR and CNR for WB-MRA. Finally, the 15 min delay win-
dow between the ﬁrst and second injections of the present
two-stage approach provided a useful time to acquire CMR
LGE data. Although a standard single dose of contrast agent
is not generally considered optimal for LGE work at 1.5 T,
recent evidence suggests that the difference between single
and double doses formyocardial infarct detection at 3 Tmay
not be signiﬁcant.30 With future reﬁnement, it would be
possible to streamline the examination further by per-
forming the ﬁrst stage of the WB-MRA acquisition initially,
and then undertaking the CMR LV assessment in the time
window between injections before completing the WB-
MRA acquisition. Other approaches to WB-MRA are also
available, for example, it would be possible to acquire the
head station with the initial injection, and then run a
standard peripheral MRA protocol to acquire abdomen,
upper leg, and lower leg stations with the second injection.
However, this approach was found to be a little more prone
to venous contamination at the lower leg position, so the
described two-injection two station method was adopted
instead because it enabled the lower leg station to be
reached more quickly.
For WB-MRA, a similar data analysis approach was
adopted to those reported elsewhere.21,22 Vessel segments
were assessed by a pool of four radiologist observers and
assigned a score (from 0e4) based on the condition of the
artery at that segment. The vast majority of arterial sites
were considered normal (Table 2), although the abdominal
aorta and coeliac axis weremore commonly associated with
some degree of pathological change (affecting up to 37.5% of
the cohort). All individuals included in the study were
clinically asymptomatic of cardiovascular disease but with a
BNP level above the gender-speciﬁc mean, suggesting a
potential cardiovascular abnormality.31
Recent published work indicates that radiological
scoring of stenoses at the coeliac axis can result in false-
positive assessments with MRI.32 This limitation may have
been borne out by the present work, although it is not a
certainty as a reference standard was not implemented
(catheter angiography is not readily applicable to whole-
body imaging). Observed stenoses at the coeliac axis were
felt to be in keeping with median arcuate ligament
compression (i.e., not an atherosclerotic process) and as
such renders the inclusion of this in the atheroma score as
questionable. Further work on larger cohorts will be
required in order to establish the MRI normal variation for
these arteries before the signiﬁcance of these data become
apparent. Aside from this, the interobserver repeatability of
the scoring systemwas very good. Radiological opinionwas
divided in only 3.3% of the 1488 cases and Fleiss kappa
(Table 2) demonstrated consistent good-excellent agree-
ment between observers. On an interobserver basis,
consistent scoringwas achieved in 93% ormore of the vesselsegments reviewed and no signiﬁcant variations between
or within observers were detected.
The development of a whole-body atheroma score based
on the accumulation of individual vessel segment scores has
been reported previously.22 This was adapted to deﬁne a
standard atheroma score (SAS) that reﬂects the total
atheroma burden (as a percentage) across an individual
subject. By including the number of segments assessed, it is
possible to account for situations where small numbers of
segments may be non-interpretable. For the present study
there was only one segment (out of 1488) that was deemed
non-interpretable by the radiologist observers. However, in
cases where patients with signiﬁcant CVD are studied then
the number of non-interpretable segments may rise and the
SAS would become less meaningful as a result.
In conclusion, the present study reported a dual-faceted
MRI protocol applied to a cohort of healthy volunteers with
low to medium risk of CVD. The protocol provides a
comprehensive cardiovascular MRI examination of WB-
MRA together with cardiac structure, function, and
myocardial LGE with a mean examination time of 51 min.
All MRI sequences are commercially available, and the
analysis methods are repeatable between single and mul-
tiple observers. The technique is potentially suitable for
future radiological investigation of patients with systemic
CVD, and may also enable the effectiveness of targeted
treatments to be monitored via individual, longitudinal, or
multi-centre investigations.
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